EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects

Jan Juřica, Miroslav Turjap

Česká a slovenská farmacie · 20.03.2025 · 74 (1) · 8-13

DOI: 10.36290/csf.2025.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Česká a slovenská farmacie, erschienen am 20.03.2025. Verfasst von Jan Juřica und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Vomiting, Nausea, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VomitingNauseaNeoplasmsAntineoplastic AgentsGastrointestinal DiseasesImmunotherapyHumans

Stichwörter der Autor:innen

gastrointestinal adverse effectsChemotherapyNauseaVomitingchemother­apyimmune-related adverse events.immunotherapyimmunother­apy

Substanzen

Antineoplastic Agents

Zitieren

APA

Juřica, J., & Turjap, M. (2025). Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects. Česká a slovenská farmacie, 74(1), 8-13. https://doi.org/10.36290/csf.2025.003

Vancouver

Juřica J, Turjap M. Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects. Česká a slovenská farmacie. 2025;74(1):8-13. doi:10.36290/csf.2025.003

BibTeX
@article{Juica2025,
  author = {Juřica, Jan and Turjap, Miroslav},
  title = {Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects},
  journal = {Česká a slovenská farmacie},
  year = {2025},
  volume = {74},
  number = {1},
  pages = {8--13},
  doi = {10.36290/csf.2025.003}
}
Kostenlos starten →